Ikena Oncology Inc (IKNA) Rapporto sugli Utili - Previsioni e Surprise Ratio

Pubblicita'

Storico dei ricavi trimestrali

IKNA rapporto: 64%

100%

IKNA supera 9 di 14 ultime stime

Data del prossimo reportNov 14, 2024

Stimato per Q3 24:$-0.27

Cambiamenti implicati per il Q2 24:0.00%

Cambiamenti implicati per il Q3 23:-32.50%

Periodo Bilanci	Data Riportata	EPS / Previsioni	Sorpresa
Q2 24	Aug 8, 2024	$-0.27 / $-0.31	$0.04 / 12.9%
Q1 24	May 13, 2024	$-0.28 / $-0.4	$0.12 / 30%
Q4 23	Mar 12, 2024	$-0.41 / $-0.41	$0 / -
Q3 23	Nov 9, 2023	$-0.4 / $-0.44	$0.04 / 9.09%
Q2 23	Aug 10, 2023	$-0.44 / $-0.48	$0.04 / 8.33%
Q1 23	May 15, 2023	$-0.39 / $-0.46	$0.07 / 15.22%
Q4 22	Mar 14, 2023	$-0.39 / $-0.53	$0.14 / 26.42%
Q3 22	Nov 7, 2022	$-0.48 / $-0.5	$0.02 / 4%

Fornitori di Dati: Xignite Logo